Scheduler

Urology Surgery Scheduler

Thursday, November 12, 2009

The plastic menace

From the AUA Daily Scope

"BPA-exposed Chinese factory workers four times as likely to suffer from ED.



The Washington Post (11/11, Layton) reports, "Exposure to high levels of a controversial chemical found in thousands of everyday plastic products appears to cause erectile dysfunction and other sexual problems in men," according to a paper in Human Reproduction. The study of "634 [BPA-exposed] male workers at four factories in China," showed that participants "were four times as likely to suffer from erectile dysfunction and seven times as likely to have difficulty with ejaculation." What's more, "sexual dysfunction began in new workers after just months on the job."


Participants were also "about four times as likely to report low sex drive or low satisfaction with their sex lives," the AP (11/11, Ritter) reports. But, Steven Hentges, a BPA expert and official with the American Chemistry Council, commented that "the work is 'probably not very relevant for consumers," adding that "the workers inhaled BPA or got it on their skin," while "consumers get it through diet." "

This is another piece of evidence in the growing body of knowledge regarding environmental toxicants.  Plastics have become ubiquitous.  Just try to go one day without consuming anything that has not come into contact with plastic.  I bet you can't do it.

BPA has been shown to be linked to a host of human diseases, from cancer to infertility and is a compound in many of our plastics.  Until recently it was present in baby bottles. 

We think of plastics in our everyday materials as inert.  I drink from plastic bottles every day.  So do my three children.  Kind of scary isn't it. 

Dr Schoor

Tuesday, November 10, 2009

TESTOPEL: One Injection every 6 months

I have been using TESTOPEL for the treatment of my male patients with hypogonadism, or sexual dysfucntion that is the result of low blood levels of testerone. 

Testosterone is the male hormone.  It is produced in the testicle and circulates in the blood in a variety of active and inactive forms.  Testosterone, in its active form DHT, acts on the many organs in the body, such as the brain, liver, circulatory system, and penis, and allow men to function normally. 

Men with low testosterone levels complain of symptoms such as ED or erectile dysfunction, low sexual drive or decreased libido, irritability, difficulty with concentration at work, and insomnia.  Some men just have vague complaints and basically just don't feel well.

Hypogonadism is diagnosed with a history, physical examination, and a blood test.  Treatment depends on the situation, but typically involves medical replacement of the testosterone.  Testerone medicaltion comes in injection, gel, or patch format. 

Urologists most often prescribe gels to treat hypogonadism.  Men must apply the gels daily in order for them to work properly. 

Some urologists prescribe injections, like testosterone cypionate.   Testosterone cypionate must be given every 3 to 4 weeks due to the rapid rise and fall of the testosterone levels with this treatment plan.  For this reason, most men choose an different form of therapy.

TESTOPEL is the newest treatment for hypogonadism in men.  TESTOPEL is an dissolvable implant that I place under the skin of the buttock once every 4 to 6 months.   In my Smithtown Long Island urology office, I have now done many Testopels.  The procedure takes under 5 minutes and is painless. 

TESTOPEL patients have been thrilled with the results.  Men like the freedom of not having to apply medication daily and they feel "normal" again.

I think it is a great procedure.

Feel free to contact me if you have any questions:  Contact

Dr Schoor

Urologist, Smithtown NY
 

Tuesday, November 03, 2009

UTI Treatment and Birth Defects

The article in quotations has ben re-printed from the AUA Daily Scope.
"Study suggests UTI treatments may be associated with increased birth defect risk.


The Los Angeles Times (11/2, Dennis) "Booster Shots" blog reported, "Doctors assume antibiotics to be fairly safe during pregnancy." And, after analyzing "data on more than 13,000 women whose babies had birth defects, comparing their antibiotic use before and during pregnancy to that of almost 5,000 women whose babies didn't have birth defects," a team at the CDC found that the assumptions about safety were mostly accurate.

Specifically, "penicillins, erythromycins, and cephalosporins...were not associated with many birth defects," Medscape (11/2, Barclay) reported. On the other hand, two classes of drugs "were associated with several birth defects."

According to the paper in the Archives of Pediatrics and Adolescent Medicine, "mothers of babies with birth defects were more likely than mothers with healthy babies to report taking two types of antibiotics during pregnancy: sulfa drugs (brand names include Thiosulfil Forte and Bactrim) and urinary germicides called nitrofurantoins (brand names include Furadantin and Macrobid)," the AP (11/3, Johnson) reports. "Used for many decades, the antibiotics in question predate the Food and Drug Administration and its requirements for rigorous safety testing." Now, the agency "grades all drugs for safety to the fetus based on available research."

Such information, however, "is sorely lacking," HealthDay (11/2, Thomas) noted. "Much of that stems from the fact that ethical considerations preclude conducting drugs trials in pregnant women," explained lead investigator Krista Crider. Moreover, "resistant strains of bacteria are forcing doctors to use a wider array of antibiotics." As expected, the CDC team "found that about 30 percent of women took an antibiotic between the three months prior to conception and the end of the pregnancy."

MedPage Today (11/2, Peck) reported, "Sulfonamides were associated with six birth defects, more than any other class: anencephaly, two left-sided heart defects, hypoplastic left heart syndrome, and coarction of the aorta, choanal atresia, transverse limb deficiency, and diaphragmatic hernia." In addition, "four defects were associated with nitrofurantoin use: anophthalmia or microphthalmos, hypoplastic left heart syndrome, atrial septal defects, and cleft lip with cleft palate." "

I think this is a very important article.  Many doctors are either cavelier about giving antibiotics for presumed urinary tract infections or are unaware of the possibility that a positive urine culture or urine analysis might actually represent a contaminated urine specimen rather than a true urinary tract or bladder infection.  A contiminated specimen does not reauire treatment with an antibiotic while a true urinary infection in pregnancy does.
 
Urine specimens become contaminated due to improper collection technique.  In women, then urethra sits right next to the vagina and the labia.  When women void, the urine can touch the vagina, labia, and pubic hair that naturally contain bacteria and white blood cells (infection cells) and drag these cells into the specimen collection cup.  Often the result is a urine analysis that looks like an infection and a positive urine culture which in turn prompts the unsuspecting doctor to treat the the patient with antibiotics when in reality, the treatment was probably not necessary.
 
The better approach to the woman with a positive UA or urine culture is to simply ask her how she feels and is she has any urinary symptoms.  If she feels fine and has no symptoms, the doctor should suspect contamination and take further steps to prove that their is or is not an true urinary tract infection.  Further steps include either repeating the urine culture as either a clean catched mid-stream specimen or as a catheterized specimen. 
 
In a pregnant woman where the implications of antibiotic usage on the unborn baby are often unknown at best, I feel that the doctor has a special obligation to prove his or her choice to prescribe antibiotics.
 
Just think about this the next time the OB-Gyn prescribes an antibiotic for your "urinary infection."
 
Dr Schoor
 
Urologist Long Island